Literature DB >> 34275087

Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury.

Mimi Wu1, Xiaoping Gu1, Zhengliang Ma2.   

Abstract

Ischemic stroke is one of the leading causes of death and also a major cause of adult disability worldwide. Revascularization via reperfusion therapy is currently a standard clinical procedure for patients with ischemic stroke. Although the restoration of blood flow (reperfusion) is critical for the salvage of ischemic tissue, reperfusion can also, paradoxically, exacerbate neuronal damage through a series of cellular alterations. Among the various theories postulated for ischemia/reperfusion (I/R) injury, including the burst generation of reactive oxygen species (ROS), activation of autophagy, and release of apoptotic factors, mitochondrial dysfunction has been proposed to play an essential role in mediating these pathophysiological processes. Therefore, strict regulation of the quality and quantity of mitochondria via mitochondrial quality control is of great importance to avoid the pathological effects of impaired mitochondria on neurons. Furthermore, timely elimination of dysfunctional mitochondria via mitophagy is also crucial to maintain a healthy mitochondrial network, whereas intensive or excessive mitophagy could exacerbate cerebral I/R injury. This review will provide a comprehensive overview of the effect of mitochondrial quality control on cerebral I/R injury and introduce recent advances in the understanding of the possible signaling pathways of mitophagy and potential factors responsible for the double-edged roles of mitophagy in the pathological processes of cerebral I/R injury.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cerebral ischemia; Mitochondrial; Mitochondrial quality control; Mitophagy; Reperfusion

Mesh:

Substances:

Year:  2021        PMID: 34275087     DOI: 10.1007/s12035-021-02494-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  175 in total

1.  Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways.

Authors:  Ying Zhang; Yue Wang; Junnan Xu; Feng Tian; Shunying Hu; Yundai Chen; Zhenhong Fu
Journal:  J Pineal Res       Date:  2019-01-31       Impact factor: 13.007

2.  Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats.

Authors:  J Aronowski; R Strong; J C Grotta
Journal:  J Cereb Blood Flow Metab       Date:  1997-10       Impact factor: 6.200

Review 3.  Acute Ischemic Stroke Therapy Overview.

Authors:  Luciana Catanese; Joseph Tarsia; Marc Fisher
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

4.  Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke.

Authors:  Lucie A van den Berg; Marcel G W Dijkgraaf; Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Hester F Lingsma; Charles B L M Majoie; Diederik W J Dippel; Aad van der Lugt; Robert J van Oostenbrugge; Wim H van Zwam; Yvo B W E M Roos
Journal:  N Engl J Med       Date:  2017-04-06       Impact factor: 91.245

5.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

Review 6.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 7.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

8.  Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.

Authors:  S Claiborne Johnston; J Donald Easton; Mary Farrant; William Barsan; Robin A Conwit; Jordan J Elm; Anthony S Kim; Anne S Lindblad; Yuko Y Palesch
Journal:  N Engl J Med       Date:  2018-05-16       Impact factor: 91.245

9.  Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials.

Authors:  Eric E Smith; Jeffrey L Saver; Margueritte Cox; Li Liang; Roland Matsouaka; Ying Xian; Deepak L Bhatt; Gregg C Fonarow; Lee H Schwamm
Journal:  Circulation       Date:  2017-10-05       Impact factor: 29.690

10.  Reperfusion promotes mitochondrial dysfunction following focal cerebral ischemia in rats.

Authors:  Jun Li; Xuesong Ma; Wei Yu; Zhangqun Lou; Dunlan Mu; Ying Wang; Baozhong Shen; Sihua Qi
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

View more
  7 in total

1.  Oridonin ameliorates caspase-9-mediated brain neuronal apoptosis in mouse with ischemic stroke by inhibiting RIPK3-mediated mitophagy.

Authors:  Lei Li; Jing-Jing Song; Meng-Xue Zhang; Hui-Wen Zhang; Hai-Yan Zhu; Wei Guo; Cai-Long Pan; Xue Liu; Lu Xu; Zhi-Yuan Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-10-10       Impact factor: 7.169

2.  Pregnenolone Attenuates the Ischemia-Induced Neurological Deficit in the Transient Middle Cerebral Artery Occlusion Model of Rats.

Authors:  Syed Suhail Andrabi; Pooja Kaushik; Sayed Md Mumtaz; Mohammad Mumtaz Alam; Heena Tabassum; Suhel Parvez
Journal:  ACS Omega       Date:  2022-06-01

3.  MicroRNA-193b-3p reduces oxidative stress and mitochondrial damage in rats with cerebral ischemia-reperfusion injury via the seven in absentia homolog 1/Jun N-terminal kinase pathway.

Authors:  Tianye Yang; Jiajun Wu; Kui Ge; Fanlin Wang; Jingxian Fan
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Editorial: Mitochondrial Dysfunction in Stroke.

Authors:  Feng Yan; Hailiang Tang; Lin Wang; Lei Huang; John Zhang
Journal:  Front Aging Neurosci       Date:  2022-03-29       Impact factor: 5.750

5.  Facilitating Mitophagy via Pink1/Parkin2 Signaling Is Essential for the Neuroprotective Effect of β-Caryophyllene against CIR-Induced Neuronal Injury.

Authors:  Jiangyan Rao; Yu Wu; Xiaomei Fan; Shaonan Yang; Lu Jiang; Zhi Dong; Sha Chen
Journal:  Brain Sci       Date:  2022-06-30

Review 6.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

7.  Docosahexaenoic Acid Alleviates Brain Damage by Promoting Mitophagy in Mice with Ischaemic Stroke.

Authors:  Eryi Sun; Jing Zhang; Yan Deng; Jun Wang; Qi Wu; Wei Chen; Xiaodong Ma; Siyuan Chen; Xin Xiang; Yujie Chen; Tairong Wu; Yang Yang; Bo Chen
Journal:  Oxid Med Cell Longev       Date:  2022-10-08       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.